Drug Discovery World

DECEMBER 7, 2022

Data analytics company Phesi analysed 2,358 clinical trials involving collagen. In the first 10 months of 2022, there were more than 225 new trials, compared with 125 in 2012. In 2021, the global collagen market was valued at $9.75 Phesi’s analysis shows that just 27% of trials received industry funding. billion by 2028.

Clinical Trials 130

Clinical Trials Trials Clinical Research Clinical Development 130

Drug Discovery World

JANUARY 25, 2023

Tom Brazier , Director Decentralised Clinical Trials, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. billion in 2021 is expected to increase by 10% year on year, to $14.2

Trials 130

Trials Clinical Trials Laboratories Nurses 130

PPD

AUGUST 16, 2023

The COVID-19 pandemic rapidly accelerated the adoption of hybrid and decentralized clinical trial (DCT) models. However, as the world settles into its post-pandemic state and returns to pre-pandemic paradigms in many areas, the pharmaceutical industry remains dedicated to moving beyond traditional, centralized clinical trial constructs.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

Vial

MAY 13, 2024

However, progress from molecule to approved drug is hampered by extremely high costs and lengthy clinical trials , and approximately 90% of drugs that reach clinical trials fail. only 5% of molecules in oncology Phase I trials reach the market taking, on average, 7.5 In 2021, a review by Rennane et al.

Clinical Trials 52

Clinical Trials Trials Production Drug Development 52

Drug Discovery Today

APRIL 15, 2021

First subjects dosed with AKS-452, COVID-19 vaccine candidate in the Netherlands trial the vaccine is shelf-stable for 4 months at 25 degrees Celsius (77° Fahrenheit). 176 volunteers will participate in the clinical trial the safety and immune response read-outs expected in Q2 2021

Clinical Trials 113

Clinical Trials Vaccine Trials Immune Response 113

Drug Discovery World

DECEMBER 6, 2023

Though this discovery is currently limited to animal models, human trials are underway. Results of a five-year clinical trial study using FGF18, known clinically as Sprifermin, were published in 2021 with potential long-term clinical benefit and no safety concerns.

Medical Schools 264

Medical Schools Clinical Trials Pharmaceuticals Trials 264

Cytel

OCTOBER 27, 2023

Speakers discussed investigator, regulatory (FDA), industry, and patient perspectives during the special symposium “Challenging the Status Quo of Early Phase Clinical Trial Design: Project Optimus.” Since its launch in 2021, Project Optimus has been reforming the dose optimization and dose selection paradigm in oncology drug development.

Clinical Trials 64

Clinical Trials Trials Clinical Pharmacology Clinical Development 64

The Pharma Data

JANUARY 4, 2021

5, 2021 07:00 UTC. February 12, 2021. March 25, 2021. 2021 First Quarter Financial Update. April 21, 2021. 2021 Second Quarter Financial Update. July 21, 2021.

Treatment 52

Treatment Trials Clinical Trials Disease 52

The Pharma Data

AUGUST 3, 2021

Revenue in the second quarter of 2021 increased 23 percent, driven by volume growth of 22 percent. – Revenue from all key products grew in the quarter and 2021 year-to-date. . – Revenue from all key products grew in the quarter and 2021 year-to-date. – 2021 EPS guidance updated to be in the range of $6.73

Production 52

Production Marketing Research Government 52

The Pharma Data

JULY 29, 2021

econd Quarter 2021 Product Sales Increased 21% Year-Over-Year Primarily Driven by Veklury. Nasdaq: GILD) announced today its results of operations for the second quarter 2021. “We Second Quarter 2021 Financial Results. Total second quarter 2021 revenue of $6.2 As of June 30, 2021, Gilead had $7.4

Science 52

Science Production Treatment FDA 52

The Pharma Data

JANUARY 12, 2021

The two-year, Phase 2 clinical trial included 272 patients with mild to moderate Alzheimer’s symptoms. The trial findings need to be replicated, Dr. Michael Weiner, a leading Alzheimer’s researcher at the University of California, San Francisco, told the Times. © 2021 HealthDay. Posted: January 2021.

Clinical Trials 52

Clinical Trials Laboratories Trials Treatment 52

The Pharma Data

JULY 29, 2021

Second-Quarter 2021 Revenues of $19.0 Billion The 10% Operational Growth Excluding BNT162b2(1) in Second-Quarter 2021 Builds on the 6% Operational Growth Delivered by the Comparable Business in Second-Quarter 2020 Second-Quarter 2021 Reported Diluted EPS(2) of $0.98, Adjusted Diluted EPS(3) of $1.07

Biosimilars 52

Biosimilars Vaccine International Production 52

The Pharma Data

DECEMBER 1, 2020

02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today released its 2021 financial calendar: March 18, 2021: Publication of 2020 financial statements. MARSEILLE, France, Dec. . .

Cell Biology 52

Cell Biology Clinical Trials Licensing Licensing 52

The Pharma Data

MAY 17, 2021

The agency noted that master protocols can save drugmakers time and money in study startup and can accelerate drug development by evaluating multiple drugs at the same time and maximizing the amount of information gained during research, compared to stand-alone trials. Read the guidance here: www.fdanews.com/05-17-21-COVID-19.pdf.

FDA 52

FDA Trials Therapies Treatment 52

Drug Discovery World

MAY 8, 2024

The ORCA-V1 trial was led by Achieve Life Sciences, and co-led by an investigator from Massachusetts General Hospital. In their previous clinical trial, the research team found that cytisinicline helped people to quit smoking traditional cigarettes. among all adults in the US and 11% among adults aged 18-24 used e-cigarettes in 2021.

Clinical Trials 182

Clinical Trials Compliance Trials Drugs 182

Drug Discovery World

DECEMBER 6, 2022

1 Vaccine development was conducted at great pace and within a year of the first infection being reported, the first Covid-19 vaccine to report phase III clinical trial data demonstrated unexpectedly high efficacy and cleared regulatory efficacy criteria with ease. Indeed, few randomised trials of NPIs have been undertaken.

Drug Development 246

Drug Development Vaccine Drugs Pharmaceuticals 246

Drug Discovery World

APRIL 18, 2024

First results from the EAGLE-1 Phase III trial for gepotidacin show that two oral doses of the antibiotic displayed superior success rates (92.6%) when compared to the combination treatment of ceftriaxone and oral azithromycin, which saw a 91.2% success rate.

Trials 130

Trials DNA Treatment Regulations 130

Advarra

JUNE 20, 2023

Additionally, in 2021, a literature review estimated the average capitalized research and development (R&D) costs per new cancer medicine at between $944 million and $4.54 Innovation Organizations conducting oncology clinical trials face challenges distinct from the rest of the research community.

Trials 52

Trials Clinical Trials FDA Approval Animal Testing 52

Drug Discovery World

SEPTEMBER 17, 2024

I am the lead scientist on our oncology and infectious disease programmes, where I manage and oversee everything related to drug discovery and work closely with our VP of Clinical Operations on our clinical trials. The highlight of my career has undoubtedly been taking on the role of Principal Scientist at Poolbeg Pharma.

Research 221

Research Clinical Trials Disease Trials 221

The Pharma Data

FEBRUARY 8, 2021

PARIS – February 5, 2021 – Today, Sanofi holds a virtual investor event with key members of the Sanofi leadership team to share and discuss the overall progress in implementing the strategy in core parts of the business as well as the transformation of R&D. Key highlights to be presented at Capital Markets Day 2021.

Marketing 52

Marketing Clinical Trials Disease Vaccine 52

Drug Discovery World

MARCH 1, 2024

Pepaxto associated with increased risk of death The FDA is alerting patients and health care professionals that a clinical trial (OCEAN, Study OP-103) evaluating Pepaxto with dexamethasone showed an increased risk of death. The FDA has now suspended enrolment in all ongoing Pepaxto clinical trials.

FDA 130

FDA Clinical Trials FDA Approval Trials 130

The Pharma Data

JANUARY 29, 2021

French vaccine company Valneva said it has begun production of its investigational COVID-19 vaccine, which is now in a phase 1/2 clinical trial in the UK. Valneva also plans to test the vaccine in more than 4,000 patients in additional trials. Martin Berman-Gorvine.

Vaccine 52

Vaccine Production Clinical Trials Government 52

The Pharma Data

MARCH 9, 2021

New data from 10 studies will be presented by Eli Lilly and Company (NYSE: LLY) at the upcoming virtual International Conference on Alzheimer’s & Parkinson Diseases 2021 (AD/PD 2021), March 9-14, 2021.

Disease 40

Disease International Research Therapies 40

The Pharma Data

AUGUST 3, 2021

today announced financial results for the second quarter of 2021. 2021 total revenues guidance reaffirmed at $25.8-$26.6 COVID-19 update : Compared to the first quarter of 2021, we have seen gradual recovery from the impacts of the COVID-19 pandemic. As a result, we expect a 50-60% year-over-year Parsabiv sales decline in 2021.

Biosimilars 52

Biosimilars Production Treatment FDA 52

The Pharma Data

MARCH 11, 2021

Eli Lilly and Company (NYSE: LLY) today announced that data from programs across its oncology portfolio and pipeline will be presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, to be held virtually April 10-15, 2021. LY3484356, an oral SERD, is currently being studied in a Phase 1/2 clinical trial.

Research 52

Research Clinical Trials FDA Approval Trials 52

The Pharma Data

JANUARY 11, 2021

Using the same technology, it is now developing a seasonal flu vaccine program to cover four seasonal viruses recommended by the World Health Organization, with a phase 1 clinical trial scheduled to begin this year. Of those two dozen programs, 13 are now in clinical trials. It has already received $2.8 It has already received $2.8

Vaccine 52

Vaccine Clinical Trials Virus RNA 52

The Pharma Data

APRIL 7, 2021

today announced new data from its expansive neuroscience portfolio will be presented at the 2021 American Academy of Neurology (AAN) Annual Meeting, to be held virtually from April 17-22. . Key AbbVie abstracts and presentation details for the 2021 AAN Annual Meeting program are outlined below. Clinical Trials Plenary Session.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52

Drug Discovery World

APRIL 13, 2023

The R21/Matrix-M vaccine has demonstrated high levels of efficacy and safety in Phase II trials, including amongst children who received a booster dose of R21/Matrix-M at one year following a primary three-dose regime. This followed 2021 results from the Phase-IIb trial reporting that R21/Matrix-M demonstrated high-level efficacy of 77%.

Vaccine 246

Vaccine Clinical Trials Trials Production 246

Drug Discovery World

JULY 30, 2024

To reach their conclusions, the team emulated seven target trials among eligible patients with comorbid T2DM and TUD by comparing the new use of semaglutide versus seven other anti-diabetes medications. The authors have called for clinical trials to evaluate semaglutide’s potential as a TUD treatment.

Trials 130

Trials Clinical Trials Treatment International 130

Drug Discovery World

DECEMBER 20, 2023

Centricity Research has acquired North Carolina-based Lucas Research, making it the fifth clinical research company to join Centricity since it launched in November 2021. With this acquisition, Centricity now has more than 35 clinical research sites, reaching 8.5 million geographically and ethnically-diverse patients.

Clinical Research 130

Clinical Research Research Clinical Trials Vaccine 130

Drug Discovery World

FEBRUARY 10, 2023

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, despite a drop in activity, according to analysis from analytics company Phesi. With an increase in available vaccines and therapies, it is not surprising that the number of recruiting trials for Covid-19 therapies has fallen.

Disease 130

Disease Clinical Trials Clinical Development Trials 130

Drug Channels

SEPTEMBER 28, 2021

on international benchmarking goes viral Amazon is finally disrupting CVS—but not how you expected Plus, the best article ever about Elizabeth Holmes’s Theranos trial. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. You can also find me on LinkedIn , where I have more than 20,000 followers. d/b/a Drug Channels Institute.

Hospitals 81

Hospitals Biosimilars Pharmacy International 81

The Pharma Data

MARCH 20, 2021

After a year of unprecedented disruption in the clinical research industry, 2021 is set to be another transformative year for sponsors and contract research organizations (CROs), according to John Reites, president of Thread, a technology and service provider focusing on decentralized clinical research. Source link: [link].

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

The Pharma Data

FEBRUARY 25, 2021

Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan. – Phase 1/2 immunogenicity and safety trials designed to include 200 healthy Japanese adults followed for 12 months after second vaccination. TAK-919 clinical trial. TAK-019 clinical trial.

Clinical Trials 52

Clinical Trials Trials Vaccine Pharmaceutical Companies 52

Drug Discovery World

JULY 31, 2024

“This lab changes that, with a leading team of investigators in a purpose-built space, working with local industry and academics to progress a range of high-quality mRNA cancer vaccine candidates from design through to preclinical evaluation, with the aim of enabling future clinical trials.”

Vaccine 147

Vaccine Clinical Trials Hospitals Treatment 147

The Pharma Data

JANUARY 11, 2021

In clinical trials, it could detect COVID-19 with 90%+ accuracy in about two minutes. . By the end of January, Johnson & Johnson is expected to deliver preliminary trial results for its one-dose COVID-19 vaccine candidate. . DalCor Pharmaceuticals initiated the Phase II dal-COVID trial of dalcetrapib for COVID-19.

Vaccine 52

Vaccine Clinical Trials Immune Response Virus 52

Fierce BioTech

JUNE 8, 2023

The 2021 WCG Avoca Industry Survey was designed to gain deeper comprehension of respondents’ values, views, and experiences regarding diversity in clinical research execution and clinical research | Gain deeper comprehension of values, views, and experiences regarding diversity in clinical research execution and participation to effectively encourage (..)

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52